トリフェニルメチルモチーフの抗がん化合物の複雑な役割について
Rahul Palchaudhuri1, Vitaliy Nesterenko, Paul J Hergenrother
1Department of Chemistry, Roger Adams Laboratory, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA.
Journal of the American Chemical Society
|July 10, 2008
まとめ
フォスフォナートを含む新しいトリフェニルメチル化合物は,がん細胞死を誘発することによって強力な抗がん活性を示しています. これらの薬剤は,独自の作用機構に基づいて,4つの異なるサブタイプに分類することができます.
科学分野:
- 薬用化学 薬用化学について
- 分子薬理学 分子薬理学
- 癌生物学 癌生物学について
背景:
- トリフェニルメチルモチーフは,新しい強力な抗がん剤に含まれています.
- いくつかのトリフェニルメチル化合物による細胞死誘導の正確なメカニズムは不明である.
- この化合物クラス内のサブタイプを区別することは,その治療的可能性を理解するために重要である.
研究 の 目的:
- 新しいトリフェニルメチルを含む小分子を合成するために.
- これらの新しい化合物の抗癌活性と作用機構を評価する.
- トリフェニルメチル化合物を,その独特の生物学的効果に基づいて分類する.
主な方法:
- トリフェニルメチルモチーフを持つ新しいリン酸塩酸およびリン酸塩酸塩酸化合物の合成.
- 複数の癌細胞系に対する化合物の細胞毒性のインビトロ評価.
- 細胞サイクル停止,チューブリンポリメリゼーション阻害,ヘキソキナーゼ解離,イオンチャネル活性などを評価するためのアッセイ.
主要な成果:
- トリフェニルメチルを含むいくつかの新しいフォスフォネートとフォスフォノクロリデートは,多様な癌細胞系に対して強力な細胞毒性を示しました.
- これらの化合物は,細胞サイクル停止,チューブリンポリメリゼーションの阻害,ミトコンドリアのヘキソキナーゼとイオンチャネルへの影響を含む様々なメカニズムを示した.
- これらの独特なメカニズムは,トリフェニルメチル化合物を少なくとも4つのカテゴリーに分類することを可能にしました.
結論:
- トリフェニルメチルを含むフォスフォナートおよびフォスフォノクロリデートは,有望な抗がん剤のクラスです.
- 特定された多様な作用メカニズムは,標的の治療戦略の可能性を強調しています.
- これらの異なるサブタイプに関するさらなる研究は,より効果的ながん治療法の開発につながる可能性があります.
関連する概念動画
01:18Aromatic Hydrocarbon Cations: Structural Overview
Cycloheptatriene is a neutral monocyclic unsaturated hydrocarbon that consists of an odd number of carbon atoms and an intervening sp3 carbon in the ring. The three double bonds in the ring correspond to 6 π electrons, which is a Huckel number, and therefore satisfies the criteria of 4n + 2 π electrons. However, the intervening sp3 carbon disrupts the continuous overlap of p orbitals. As a result, cycloheptatriene is not aromatic.
Removing one hydrogen from the intervening CH2 group with both...
Removing one hydrogen from the intervening CH2 group with both...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...